Biological behaviour and clinical implications of micrometastases

British Journal of Surgery

Volumn 87, Issue 12, 2000, Pages 1629-1639

  Kell, M R ^a   Winter, D C ^a   O'Sullivan, G C ^b   Shanahan, F ^a   Redmond, H P ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL INFORMATION; MELANOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; REVIEW;

BIOPSY, NEEDLE; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS;

EID: 0033673378     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01606.x     Document Type: Review

References (127)

1. The experimental study of tumor progression. A review
2. Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology
3. Tumour dormancy: Not so sleepy after all
4. Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer
5. Micrometastasis in bone marrow in breast cancer
6. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance
7. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients
8. Predictive value of genetic diagnosis for cancer micrometastasis: Histologic and experimental appraisal
9. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
10. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer
11. Tumor behavior in isolated perfused organs: In vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment
12. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium
13. Surgical implications of therapeutic angiogenesis
14. Dormancy of micrometastasis: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
15. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
16. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
17. Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscle
18. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
19. Requirement of vascular alpha v beta integrin for angiogenesis
20. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
21. Definition of two angiogenic pathways by distinct alpha v integrins
22. Expression of vascular endothelial growth factor, and its receptors, and other angiogenic factors in human breast cancer
23. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
24. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
25. Vascular endothelial growth factor as a marker of tumor endothelium
26. Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: Association with regions of necrosis
27. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells
28. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
29. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)
30. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds
31. PDGF and FGF stimulate wound healing in the genetically diabetic mouse
32. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing
33. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
34. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
35. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF
36. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
37. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
38. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
39. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
40. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
41. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
42. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis
43. Analysis of experimental antiangiogenic therapy
44. Detection of occult nodal metastases in patients with colorectal carcinoma
45. Technical details of intraoperative lymphatic mapping for early stage melanoma
46. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma
47. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
48. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy
49. The catolog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
50. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence
51. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins
52. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival
53. Early carcinoma of the stomach
54. Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance
55. Detection of ras gene mutations in the perioperative peripheral blood in patients with pancreatic adenocarcinoma
56. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
57. The molecular detection of circulating tumour cells
58. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
59. Diagnosis of micrometastases by the amplification of tissue-specific genes
60. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction
61. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value
62. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20
63. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)
64. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method
65. Genetic diagnosis of lymph-node metastasis in colorectal cancer
66. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma
67. 125I-radiolabeled monoclonal antibody CC49
68. Clearance technique for the detection of lymph nodes in colorectal cancer
69. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance
70. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
71. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
72. Micrometastases in bone marrow of patients undergoing 'curative' surgery for gastrointestinal cancer
73. Micrometastases: Marker of metastatic potential or evidence of residual disease?
74. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in-vivo labeling with anti-17-1A monoclonal antibodies
75. Micrometastatic tumour cells in bone marrow in colorectal cancer
76. Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients
77. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
78. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
79. Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA
80. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
81. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
82. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease
83. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen
84. Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19
85. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer
86. Cancer metastasis is selective or random depending on the parent tumour population
87. The biology of human cancer metastasis. 7th Jan Waldenstrom Lecture
88. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis
89. Physiologic resection of the right colon
90. Cancer of the colon: The influence of the no-touch isolation technique on survival rates
91. No-touch isolation technique in colon cancer: A controlled prospective trial
92. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study
93. Follow-up of patients operated on for colorectal carcinoma
94. Immunohistochemical evaluation of lymph node micrometastases from breast cancer
95. Significance of axillary macrometastases and micrometastases in mammary cancer
96. Significance of occult metastases. A study of breast cancer
97. Comparative analyses of bone marrow micrometastases in breast and gastric cancer
98. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
99. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients
100. Axillary micrometastasis and macrometastasis in carcinoma of the breast
101. Breast cancer: Two micrometastatic variants in the axilla that differ in prognosis
102. Sentinel lymphadenectomy in breast cancer
103. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
104. Combined sentinel lymph-node mapping and bone-marrow micrometastatic analysis for improved staging in breast cancer
105. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up
106. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival
107. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease
108. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
109. Cutanous melanoma
110. Benefit of elective lymph node dissection in subgroups of melanoma patients: Results of a multicenter study of 3616 patients
111. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
112. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
113. Cytokeratin staining reveals micrometastasis in lymph nodes of early gastric cancer
114. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
115. Micrometastatic turnout cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance
116. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
117. Progress in treating esophageal adenocarcinoma
118. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract
119. Micrometastases from squamous cell carcinoma in neck dissection specimens
120. Micrometastases in carcinoma of the upper aerodigestive tract: Detection, risk of metastasizing, and prognostic value of depth of invasion
121. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections
122. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining
123. Detailed topography of cervical lymph-node metastases from oral squamous cell carcinoma
124. Pathology of the No neck
125. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: Incidence, histopathological features and clinical implications
126. The gamma-probe-guided resection of radiolabeled primary lymph nodes
127. Micrometastases in bone marrow of patients with cancers in the head and neck area